These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3513440)

  • 21. [Cell-mediated cytotoxicity--CML test (author's transl)].
    Pruzinec P; Buc M
    Bratisl Lek Listy; 1982 Feb; 77(2):159-64. PubMed ID: 6978169
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of HL-A typing with NIH trays and the NIH technique with typing by the fluorochromasia cytotoxicity assay.
    Perkins HA; Howell E; Gantan Z; Ross J
    Transfusion; 1975; 15(4):340-5. PubMed ID: 1101467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two techniques to make the lymphocytotoxic crossmatch more sensitive: prolonged incubation and the antiglobulin test.
    Ross J; Dickerson T; Perkins HA
    Tissue Antigens; 1975 Sep; 6(3):129-36. PubMed ID: 1181663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HL-A antigens in pemphigus.
    Katz SI; Dahl MV; Penneys N; Trapani RJ; Rogentine N
    Arch Dermatol; 1973 Jul; 108(1):53-5. PubMed ID: 4577494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Examination using fluorescence in clinical practice].
    Horvat Z; Janković D
    Reumatizam; 1979; 26(4):137-43. PubMed ID: 392669
    [No Abstract]   [Full Text] [Related]  

  • 27. Allogeneic antibodies detected by inhibition of lymphocyte reactivity and by immunofluorescence.
    Carbonara AO; De Marchi M; Trinchieri G; Varetto O; Curtoni ES; Ceppellini R
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):133-53. PubMed ID: 4606190
    [No Abstract]   [Full Text] [Related]  

  • 28. The fluorochromasia test complicated by enhanced fluorescein loss.
    Bruning JW; Kardol MJ; Naipal A
    Tissue Antigens; 1975 Jul; 6(1):37-9. PubMed ID: 1154367
    [No Abstract]   [Full Text] [Related]  

  • 29. Positive autocrossmatch and slough of the ureteral mucosa: a case report.
    Halasz NA; Rearden CA; Parsons CL; Talner LB
    Transplant Proc; 1982 Dec; 14(4):743-7. PubMed ID: 6762734
    [No Abstract]   [Full Text] [Related]  

  • 30. Turnover of HL-A antigens at the lymphocyte surface.
    Bernoco D; Mattiuz PL; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):272-84. PubMed ID: 4949682
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternative fluorochromes to ethidium bromide for automated read out of cytotoxicity tests.
    Tanke HJ; van der Linden PW; Langerak J
    J Immunol Methods; 1982; 52(1):91-6. PubMed ID: 6749996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paul Ichiro Terasaki (1929-2016): Inventor of the microcytotoxicity assay and pioneer tissue typer.
    Bodmer WF
    HLA; 2016 May; 87(5):333-7. PubMed ID: 27101942
    [No Abstract]   [Full Text] [Related]  

  • 33. Crossmatching technique facilitating kidney transplantation.
    Buabut B; Chiewsilp P; Patanapanyasat K; Jirasiritham S; Mavichak V; Sujirachato K; Mongkolsuk T
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S55-61. PubMed ID: 9347647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histocompatibility testing for highly sensitized transplant candidates.
    Saidman SL
    Transplant Proc; 2007 Apr; 39(3):673-5. PubMed ID: 17445570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA typing by Reference Strand Mediated Conformation Analysis (RSCA).
    Argüello JR; Madrigal JA
    Rev Immunogenet; 1999; 1(2):209-19. PubMed ID: 11253947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of the human T and B lymphocyte population using immunofluorescence and cytotoxicity tests with monoclonal antibodies].
    Koubek K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Sep; 31(5):286-9. PubMed ID: 6215995
    [No Abstract]   [Full Text] [Related]  

  • 38. [Optical immunofluorescence detection of alloantibodies as a supplement to classical crossmatching within the scope of organ transplantation].
    Lanzer G; Neubauer M
    Wien Med Wochenschr; 1986 Nov; 136(21-22):554-6. PubMed ID: 3548083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Typing for the MLC determinants and its possible impact on Europdonor.
    van Rood JJ; van Leeuwen A; van den Tweel JG; Blussé van Oud Alblas A; Keuning JJ; Eernisse JG
    Transplant Proc; 1974 Dec; 6(4):411-5. PubMed ID: 4140594
    [No Abstract]   [Full Text] [Related]  

  • 40. Solid phase testing in the HLA laboratory: implications for organ allocation.
    Eckels DD
    Int J Immunogenet; 2008 Aug; 35(4-5):265-74. PubMed ID: 18479450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.